Table 2.
Effect of BA treatment on VLP * binding to PGM.
| Genotype | Accession Number | GCDCA Effect on Binding |
|---|---|---|
| GI.1 | M87661 | No effect |
| GI.2 | FJ515294 | No effect |
| GI.4 | GQ413970 | No effect |
| GI.5 | KJ402295 | No effect |
| GI.6 | KC998959 | No effect |
| GI.7 | JN005886 | No effect |
| GI.8 | GU299761 | No binding +/−GCDCA |
| GII.1 | JN797508 | GCDCA permits binding |
| GII.2 | AY134748 | GCDCA permits binding |
| GII.3_2002 | KF006265 | No binding +/−GCDCA |
| GII.3_2004 ** | AB365435 | No effect |
| GII.4_Sydney | JX459908 | No effect |
| GII.5 | AF414422 | No effect |
| GII.6 | GU930737 | No effect |
| GII.7 | KF006266 | No effect |
| GII.8 | AB039780 | No effect |
| GII.9 | DQ379715 | No effect |
| GII.10 | AF504671 | No binding +/−GCDCA |
| GII.12 | KF006267 | GCDCA permits binding |
| GII.13 | JN899242 | Enhancement of binding |
| GII.14 | GU594162 | Enhancement of binding |
| GII.15 | GQ856474 | No binding +/−GCDCA |
| GII.17 | DQ438972 | No effect |